[{"status": "Terminated", "city": "Aiken", "state": "SC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67800", "recalling_firm": "GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline", "address_1": "65 Windham Blvd", "address_2": "N/A", "postal_code": "29805-9384", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1242-2014", "product_description": "Nicotine polacrilex lozenge, 2 mg, Mint Flavor, 81 count cartons and 189 count cartons. OTC. Labeled Nicorette, Distributed By: GlaxoSmithKline Consumer Healthcare, L.P., Moon Township, PA 15108.  Made in Switzerland. 81 Count NDC: 0135-0510-05, 189 Count NDC: 0135-0510-03.", "product_quantity": "147,684 81 Ct Vials, 130564 189 Ct Vials", "reason_for_recall": "Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.", "recall_initiation_date": "20140220", "center_classification_date": "20140418", "termination_date": "20170120", "report_date": "20140430", "code_info": "81 Ct Vial, Lot # 13727 (exp 8/14), 13816 (exp 10/14), & 13965 (exp 12/14); 189 Ct Vial, Lot # 12H17N (exp 4/14), 12H20N (exp 6/14), 12J16N (exp 6/14), 12K03N (exp 9/14), 12L05N (exp 10/14), 12L07N (exp 9/14), 12L17N (exp 10/14), 13A04N (exp 11/14), 13A23N (exp 11/14), 13C04N (exp 1/15), 13C08N (exp 1/15), 13D17N (exp 11/14), 13D18N (exp 1/15), 13D18N1 (exp 3/15), 13E24N (exp 4/15), 13E28N (exp 4/15), 13G16N (exp 4/15), 13G17N (exp 5/14), 13H02N (exp 5/15), 13H22N (exp 5/15), 13I18N (exp 8/15), 13I20N (exp 5/15), 13J24N (exp 8/15), 13J24N1 (exp 9/15), 13K08N (exp 8/15), 13K11N (exp 9/15), 13L11N (exp 10/15) & 13L11N1 (exp 10/15).", "more_code_info": ""}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68069", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1324-2014", "product_description": "BUPRENORPHINE HYDROCHLORIDE Sublingual Tablets, 2 mg, 30-count bottles, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-5378-56, UPC 3 0093-5378-56 5.", "product_quantity": "17,181 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: High out of specification impurity test results were obtained during stability testing.", "recall_initiation_date": "20140407", "center_classification_date": "20140516", "termination_date": "20141120", "report_date": "20140528", "code_info": "Lot #: 34013132A, 34013133A, 34013134A, 34013135A, 34013136A, Exp 11/14"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA017427"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0048"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["IRRIGATION"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["486515"], "spl_id": ["123eac3f-8e50-4689-bf00-cf9407eb70ee"], "spl_set_id": ["b3b4b176-41f0-4ca8-90d4-3fba5707564a"], "package_ndc": ["0338-0048-02", "0338-0048-03", "0338-0048-04", "0338-0048-05"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "67974", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide", "recall_number": "D-1282-2014", "product_description": "0.9% Sodium Chloride Irrigation, USP, 1000 mL,Not for Injection,  Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0048-04.", "product_quantity": "211,752 bottles", "reason_for_recall": "Presence of Particulate Matter: Nylon fibers found in a bottle of 0.9% sodium chloride for irrigation.", "recall_initiation_date": "20140421", "center_classification_date": "20140428", "termination_date": "20150224", "report_date": "20140507", "code_info": "Lot # Gl09272; Exp 09/16", "more_code_info": ""}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA017512"], "brand_name": ["DIANEAL LOW CALCIUM WITH DEXTROSE"], "generic_name": ["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"], "manufacturer_name": ["Vantive US Healthcare LLC"], "product_ndc": ["0941-0409", "0941-0411", "0941-0413", "0941-0415", "0941-0457", "0941-0459", "0941-0426", "0941-0427", "0941-0429", "0941-0424", "0941-0430", "0941-0433", "0941-0484", "0941-0487", "0941-0490"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "rxcui": ["799999", "800003", "800057", "800061", "800062", "800064", "800066", "800074", "800111", "800115", "800472", "800474"], "spl_id": ["36ea94f6-f614-9531-e063-6294a90aae55"], "spl_set_id": ["aa268d3f-7389-4f25-801f-5d4825495f08"], "package_ndc": ["0941-0411-05", "0941-0411-06", "0941-0411-07", "0941-0411-04", "0941-0411-11", "0941-0413-05", "0941-0413-06", "0941-0413-07", "0941-0413-01", "0941-0413-04", "0941-0415-05", "0941-0415-06", "0941-0415-04", "0941-0415-07", "0941-0415-01", "0941-0409-06", "0941-0409-05", "0941-0409-07", "0941-0409-01", "0941-0457-08", "0941-0457-02", "0941-0457-05", "0941-0457-01", "0941-0459-08", "0941-0459-02", "0941-0459-05", "0941-0459-01", "0941-0426-52", "0941-0426-53", "0941-0426-55", "0941-0427-52", "0941-0427-53", "0941-0427-55", "0941-0429-52", "0941-0429-53", "0941-0429-55", "0941-0424-51", "0941-0424-52", "0941-0424-53", "0941-0424-55", "0941-0430-51", "0941-0430-52", "0941-0430-53", "0941-0430-55", "0941-0433-51", "0941-0433-52", "0941-0433-53", "0941-0433-55", "0941-0484-01", "0941-0487-01", "0941-0490-01"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "67608", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1276-2014", "product_description": "Dianeal PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose, 6000 mL Ambu-Flex II container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product Code L5B9710, NDC 0941-0411-11", "product_quantity": "27,169 containers", "reason_for_recall": "Non-Sterility: Complaints of leaks and particulate matter identified as mold in the solution bag and the overpouch.", "recall_initiation_date": "20140211", "center_classification_date": "20140425", "termination_date": "20150722", "report_date": "20140507", "code_info": "Lot number: C903799, Exp 05/15", "more_code_info": ""}, {"country": "United States", "city": "Irvine", "address_1": "2525 McGaw Ave", "reason_for_recall": "Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.", "address_2": "", "product_quantity": "4614 units", "code_info": "Lot# J2H002, Exp 06/14; J2S018, Exp 12/14", "center_classification_date": "20140425", "distribution_pattern": "Nationwide, Puerto Rico and Spain", "state": "CA", "product_description": "6.9% FreAmine HBC (Amino Acid Injection), partial fill container 750 mL in a 1000 mL container, Catalog No. S9350-58SS, Sterile, Single dose container, Rx Only, B Braun Medical Inc., Irvine, CA 92614-5895, NDC 0264-9350-55", "report_date": "20140507", "classification": "Class I", "openfda": {}, "recalling_firm": "B. Braun Medical Inc", "recall_number": "D-1271-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "66913", "termination_date": "20141204", "more_code_info": "", "recall_initiation_date": "20131121", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1194-2014", "product_description": "Pleo Not TABLETS 5X, 20 Tablet Cartons, Oral Homeopathic Medicine, OTC Only. Made in Germany, Distributed by: SANUM USA Corp.,1465 Slater Road, Fernadale, WA 98248;  Manufactured By: SANUM-Kehlbeck GmbH & Co. KG. NDC: 49807-2302-1.", "product_quantity": "4955 cartons", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "Batch # 15070, EXP: June 2015; Batch # 24072, EXP: June 2017."}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "66913", "recalling_firm": "B. Braun Medical Inc", "address_1": "2525 McGaw Ave", "address_2": "", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico and Spain", "recall_number": "D-1275-2014", "product_description": "Hyperlyte CR (Multi-Electrolyte Concentrate), 20 mL/dose, 250 mL Container, Catalog No. S9432, Rx Only, Sterile, B Braun Medical Inc., Irvine CA 92614-5895, In Canada Dist by: B Braun Medical Inc., Scarborough, Ontario M1H 2W4, NDC 0264-1943-20, Canada DIN 01924311", "product_quantity": "5,592 units", "reason_for_recall": "Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.", "recall_initiation_date": "20131121", "center_classification_date": "20140425", "termination_date": "20141204", "report_date": "20140507", "code_info": "Lot# J3B007, Exp 08/14", "more_code_info": ""}, {"status": "Terminated", "city": "Nixa", "state": "MO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67228", "recalling_firm": "Schindele Enterprises dba Midwest Wholesale", "address_1": "617 N Althea Ave", "address_2": "N/A", "postal_code": "65714-7432", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI", "recall_number": "D-1337-2014", "product_description": "MiracleZEN Platinum, 1 pill blister pack, 2000 mg capsule, Distributed by: Power Life Distributors, COK Inc., Los Angeles, CA.", "product_quantity": "49 blister packs", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.", "recall_initiation_date": "20140109", "center_classification_date": "20140520", "termination_date": "20150203", "report_date": "20140528", "code_info": "1 pill blister packs: Lot  OAWF 1027 Exp 1/31/2015 and  Lot OAWF1003 Exp 01/31/2015."}, {"status": "Terminated", "city": "Deltona", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67471", "recalling_firm": "MyNicNaxs, Inc.", "address_1": "1012 Alpine Dr", "address_2": "N/A", "postal_code": "32725-7204", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1379-2014", "product_description": "Magic Slim capsules, supplied in 60 count bottles, distributed by MyNicKnaxs, LLC, Deltona, FL", "product_quantity": "unknown", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredients: N-desmethylsibutramine, benzylsibutramine, and sibutramine", "recall_initiation_date": "20140124", "center_classification_date": "20140612", "termination_date": "20191002", "report_date": "20140618", "code_info": "ALL LOTS"}, {"status": "Terminated", "city": "Deltona", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67471", "recalling_firm": "MyNicNaxs, Inc.", "address_1": "1012 Alpine Dr", "address_2": "N/A", "postal_code": "32725-7204", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1378-2014", "product_description": "Slim Xtreme Weight loss capsules, 500 mg, supplied in 30 count bottles, Another product from Globe All Wellness, LLC Hollywood, FL 33020, distributed by MyNicKnaxs, LLC Deltona, FL", "product_quantity": "unknown", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredient: N-desmethylsibutramine, benzylsibutramine, and sibutramine", "recall_initiation_date": "20140124", "center_classification_date": "20140612", "termination_date": "20191002", "report_date": "20140618", "code_info": "ALL LOTS"}, {"status": "Terminated", "city": "Fajardo", "state": "PR", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67162", "recalling_firm": "Deseo Rebajar", "address_1": "G12 Calle Principal", "address_2": "Baralt Ste #3", "postal_code": "00738-3774", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Puerto Rico only", "recall_number": "D-1351-2014", "product_description": "Burn 7 Capsules, supplied in 30 capsules bottle", "product_quantity": "120 bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Undeclared sibutramine and phenolphthalein  in Burn 7 dietary supplement", "recall_initiation_date": "20131223", "center_classification_date": "20140527", "termination_date": "20170503", "report_date": "20140604", "code_info": "MFD: 07.18.2013,  EXP: 07.17.2015", "more_code_info": ""}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67664", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "N/A", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Guam, Puerto Rico, American Samoa, Virgin Islands.", "recall_number": "D-1183-2014", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 30 Capsules per Bottle, Manufactured in Israel by: Teva Pharmaceutical IND, LTD, Jerusalem, Israel, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA, 18960, NDC 0093-7543-56", "product_quantity": "598,033 Bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a customer complaint trend regarding capsule breakage.", "recall_initiation_date": "20140304", "center_classification_date": "20140401", "termination_date": "20141112", "report_date": "20140409", "code_info": "Lot #:  49D001, Exp. 4/2015; 49D002, Exp. 6/2015;  49D003, Exp. 7/2015; 49D004, 49D005, 49D006, Exp. 9/2015; 49D007, Exp. 10/2015"}, {"status": "Completed", "city": "Asbury Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68158", "recalling_firm": "Flawless Beauty LLC", "address_1": "1215 Main St", "address_2": "", "postal_code": "07712-5940", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1320-2014", "product_description": "Vitamin C (ascorbic acid) Injection, USP, 500 mg per 2 mL, 50 x 2 mL ampoules per box, Manufactured by: TP Drug Laboratories (1969) Co., Ltd., 98 Soi Sukhumvlt 62, Yak 1, Bangchak, Prakanong, Bangkok 10260, Thailand, Reg. No. 1 A 1557/30; UPC 8 853533 000533", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Parenteral product is sold over the counter whose labeling indicates it is to be used for the treatment of disease.", "recall_initiation_date": "20140429", "center_classification_date": "20140513", "report_date": "20140521", "code_info": "Lot #: 556273, Exp 9/25/16; 556219, Exp 8/2/16, or any other lot distributed by Flawless Beauty.", "more_code_info": ""}, {"status": "Terminated", "city": "Nashville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68557", "recalling_firm": "John W Hollis Inc", "address_1": "110 20th Ave N", "address_2": "N/A", "postal_code": "37203-2315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1392-2014", "product_description": "Testosterone Cypionate for Injection, each mL contains Testosterone Cypionate 200 mg, also contains:  Cotton Seed Oil, Benzyl Benzoate, Benzyl Alcohol, Rx Only, 10 mL, JOHN HOLLIS Pharmacist, Inc. 110 20th Avenue N, Nashville, TN 37203, 615-327-3234", "product_quantity": "50 mL", "reason_for_recall": "Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.", "recall_initiation_date": "20140512", "center_classification_date": "20140618", "termination_date": "20140702", "report_date": "20140625", "code_info": "lot# 1157, Use by 09/16/14; lot# 2357, use by 06/01/14", "more_code_info": ""}, {"status": "Terminated", "city": "Attleboro", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68136", "recalling_firm": "Mangiacotti", "address_1": "117 Pleasant Street", "address_2": "N/A", "postal_code": "02703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1304-2014", "product_description": "Mangiacotti\t - Lavender Hand Sanitizer Spray, alcohol free, 0.5 fl Oz. 15 mL spray bottle, UPC 870678005313, Active Ingredient Benzalkonium Chloride 0.1%, Dist by: Mangiacotti, Attleboro, MA 02703 .", "product_quantity": "N/A", "reason_for_recall": "Microbial Contamination of Non-Sterile Products:  Elevated counts of bacteria was found, Serratia liquefaciens.", "recall_initiation_date": "20131227", "center_classification_date": "20140506", "termination_date": "20160429", "report_date": "20140514", "code_info": "Lot Code:  13348"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67564", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "N/A", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1190-2014", "product_description": "QVAR\u00bf (beclomethasone dipropionate HFA), C4 INHALATION AEROSOL in Aluminum Cylinders, Mktd by: Teva Respiratory, LLC, Horsham, PA 19044  Mfd by: 3M Drug Delivery Systems, Northridge, CA 91324.", "product_quantity": "257,832 cylinders", "reason_for_recall": "Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time point", "recall_initiation_date": "20140211", "center_classification_date": "20140403", "termination_date": "20141114", "report_date": "20140409", "code_info": "lot 120088, exp.3/2014, NDC 59310-202-40, 40 mcg,8.7g / 120 metered inhalations, lot 120491, exp. 10/2014, NDC 59310-175-41,40 mcg,7.3g / 100 metered inhalations"}, {"country": "United States", "city": "Irving", "address_1": "8300 Esters Blvd Ste 940", "reason_for_recall": "Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.", "address_2": "", "product_quantity": "296 units", "code_info": "Lot Numbers 101751/A, Exp: 05/16, CAS: 9002-61-3; 101752/A, Exp: 05/16,  CAS 9002-61-3;  and 101799/A, Exp: 05/16, CAS: 9002-61-3.  NDC 38779-2673-1, NDC 38779-2673-2, and NDC 38779-2673-6.", "center_classification_date": "20140425", "distribution_pattern": "Nationwide", "state": "TX", "product_description": "Human Chorionic Gonadotropin, EP (HCG) in 5 mu. 2 mu, and 1 mu packages, For use and distribution in prescription compounding, manufacturing, processing or repacking only in accordance with FDA regulations and applicable law.  Potency 5489.6IU/mg.  Packed by Medisca, Inc. Irving, TX, 75063, USA      NDC 38779-2673-1, NDC 38779-2673-2, and NDC 38779-2673-6.      Lot Numbers 101751/A, Exp: 05/16, CAS: 9002-61-3; 101752/A, Exp: 05/16,  CAS 9002-61-3;  and 101799/A, Exp: 05/16, CAS: 9002-61-3", "report_date": "20140507", "classification": "Class I", "openfda": {}, "recalling_firm": "Medisca Inc.", "recall_number": "D-1263-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67114", "termination_date": "20161116", "more_code_info": "", "recall_initiation_date": "20131021", "postal_code": "75063-2272", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Williamstown", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "66406", "recalling_firm": "Haute Health, LLC", "address_1": "614 Atlanta Ct", "address_2": "N/A", "postal_code": "08094-3549", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and internationally via internet sales.", "recall_number": "D-1237-2014", "product_description": "Virilis Pro, 450mg/capsule, Packaged in a 1 and 2 capsule blister packs and 10 capsule bottles, Manufactured for Haute Health Williamstown, NJ 08094 website: http://www.virilispro.com", "product_quantity": "82,944 capsules", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Dietary supplement may contain amounts of  active ingredients found in some FDA-approved drugs for erectile dysfunction (ED) making the dietary supplement an unapproved drug.", "recall_initiation_date": "20130927", "center_classification_date": "20140415", "termination_date": "20150129", "report_date": "20140423", "code_info": "All lot codes and expiration dates."}, {"country": "United States", "city": "Easton", "address_1": "8050 Industrial Park Rd", "reason_for_recall": "Labeling: Label Error on Declared Strength; Listed active ingredient strength is inaccurate.", "address_2": "", "product_quantity": "6286 Bottles", "code_info": "Lot #: A44701 (expiry:  07/16) , A44701C (expiry: 07/16), J34701C-1 (expiry: 07/16)", "center_classification_date": "20140513", "distribution_pattern": "USA including FL, MN,  NY, OH, OR, PA, TX, SC and Puerto Rico; Dominican Republic.", "state": "MD", "product_description": "PSYLLIUM FIBER, Laxative/Supplement, 100 Capsules, OTC.  Manufactured By: Konsyl Pharmaceuticals, Inc., Easton, MD 21601. NDC: 0224-1847-10.", "report_date": "20140521", "classification": "Class III", "openfda": {}, "recalling_firm": "Konsyl Pharmaceuticals Inc", "recall_number": "D-1315-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68052", "termination_date": "20160526", "more_code_info": "", "recall_initiation_date": "20140401", "postal_code": "21601-8602", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "65383", "recalling_firm": "Dolphin Intertrade Corporation", "address_1": "11314 Sw 135th Ct", "address_2": "N/A", "postal_code": "33186-4425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1250-2014", "product_description": "XIYOUJI QINGZHI CAPSULE, 300mg, 20 count box", "product_quantity": "8 bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.", "recall_initiation_date": "20130520", "center_classification_date": "20140418", "termination_date": "20160629", "report_date": "20140430", "code_info": "All Lots", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065462"], "brand_name": ["CEFPODOXIME PROXETIL"], "generic_name": ["CEFPODOXIME PROXETIL"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-5438", "0781-5439"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFPODOXIME PROXETIL"], "rxcui": ["309076", "309078"], "spl_id": ["6878b572-5711-43a8-9972-1410927f1f14"], "spl_set_id": ["8519a9d8-7106-4545-bc58-859ee9a6708e"], "package_ndc": ["0781-5438-20", "0781-5438-01", "0781-5439-20", "0781-5439-01"], "is_original_packager": [true], "upc": ["0307815439019", "0307815439200", "0307815438203"], "unii": ["2TB00A1Z7N"]}, "product_type": "Drugs", "event_id": "68360", "recalling_firm": "Sandoz, Inc", "address_1": "506 Carnegie Ctr Ste 400", "address_2": "", "postal_code": "08540-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide including Puerto Rico.", "recall_number": "D-1350-2014", "product_description": "Cefpodoxime Proxetil Tablets, USP, 200 mg, 20 Tablet Bottles, Rx Only. Manufactured in Austria by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540. NDC 0781-5439-20.", "product_quantity": "22,818 Bottles", "reason_for_recall": "Presence of Foreign Substance: Presence of stainless steel particles.", "recall_initiation_date": "20140522", "center_classification_date": "20140523", "termination_date": "20150205", "report_date": "20140604", "code_info": "Lot #: DZ4056, Expiry: 11/2015;  Lot # DZ4057, Expiry: 01/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Nashville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68557", "recalling_firm": "John W Hollis Inc", "address_1": "110 20th Ave N", "address_2": "N/A", "postal_code": "37203-2315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1400-2014", "product_description": "Papaverine HCl 30 mg, Phentolamine Mesylate 1 mg, a) 5 mL and b) 10 mL, JOHN HOLLIS Pharmacist, Inc 110 20th Avenue N, Nashville, TN 37203, 615-327-3234", "product_quantity": "170 mL", "reason_for_recall": "Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.", "recall_initiation_date": "20140512", "center_classification_date": "20140618", "termination_date": "20140702", "report_date": "20140625", "code_info": "a) 5 mL: Lot: 2297, best used by 6/04/14; Lot: 2578, best used by 6/25/14; Lot: 2672, best used by 7/03/14; Lot: 3022, best used by 7/28/14;   b) 10 mL: Lot: 2166, best used by 5/26/14; Lot: 2297, best used by 6/04/14; Lot: 2578, best used by 6/25/14", "more_code_info": ""}, {"status": "Terminated", "city": "North Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020517"], "brand_name": ["LUPRON DEPOT"], "generic_name": ["LEUPROLIDE ACETATE"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-3346", "0074-3473", "0074-3683", "0074-3642"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "spl_id": ["98a4f293-ee7c-44d0-9a1e-9dc7faf8aaf8"], "spl_set_id": ["cbc8f94e-7330-4465-05ad-16d64493a5dd"], "package_ndc": ["0074-3473-03", "0074-3683-03", "0074-3642-03", "0074-3346-03"], "is_original_packager": [true], "upc": ["300743473032"]}, "product_type": "Drugs", "event_id": "67709", "recalling_firm": "AbbVie Inc", "address_1": "1 N Waukegan Rd", "address_2": "", "postal_code": "60064", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1288-2014", "product_description": "Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 45 mg for 6-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL  60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3473-03, UPC 3 00743 47303 2.", "product_quantity": "36 kits", "reason_for_recall": "Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.", "recall_initiation_date": "20140310", "center_classification_date": "20140429", "termination_date": "20160622", "report_date": "20140507", "code_info": "Lot # 1013976, Exp 09/25/15", "more_code_info": ""}, {"status": "Terminated", "city": "Whitehouse Station", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67344", "recalling_firm": "Merck & Co Inc", "address_1": "1 Merck Dr", "address_2": "P.O. Box 100", "postal_code": "08889-3400", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1312-2014", "product_description": "Liptruzet (ezetimibe and atorvastin) tablets,10 mg/80 mg, a) 30 count blister    (NDC 66582-323-30), b) 90 count blister  (NDC 66582-323-54), Rx only, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc, Whitehouse Station, NJ 08889", "product_quantity": "11,462 cartons", "reason_for_recall": "Defective Container; some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.", "recall_initiation_date": "20140113", "center_classification_date": "20140506", "termination_date": "20150902", "report_date": "20140514", "code_info": "a) Liptruzet 10/80mg 30 count, 346379, 350257, Exp.07/14; 353591, Exp. 06/15.   b) Liptruzet 10/80mg 90 count,  346383, 371072, Exp. 06/15."}, {"country": "United States", "city": "Vernon Hills", "address_1": "75 N Fairway Dr", "reason_for_recall": "Subpotent Drug: CareFusion is recalling the CareFusion Scrub Care Surgical Scrub Brush-Sponge/Nail Cleaner. The available iodine in the product is less than as stated on the product label.", "address_2": "", "product_quantity": "1,662,000 Surgical Scrub Brushes", "code_info": "4452B", "center_classification_date": "20140605", "distribution_pattern": "Nationwide and Puerto Rico; Bahrain, Germany, Mexico, Philippines", "state": "IL", "product_description": "CareFusion Scrub Care Surgical Scrub Brush-Sponge/Nail Cleaner With 15% Povidone-iodine (USP) Surgical Hand Scrub; CareFusion, Vernon Hills, IL 60061 USA,  NDC 57613-013-15.", "report_date": "20140611", "classification": "Class II", "openfda": {}, "recalling_firm": "Carefusion 2200 Inc", "recall_number": "D-1360-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68176", "termination_date": "20150611", "more_code_info": "", "recall_initiation_date": "20131220", "postal_code": "60061-1845", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67080", "recalling_firm": "Zions RX Formulations Services LLC dba RX Formuations Serv.", "address_1": "5949 E University Dr", "address_2": "N/A", "postal_code": "85205-7435", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "AZ", "recall_number": "D-1217-2014", "product_description": "Sodium Bicarbonate 8.4%, a) 10 mL, b) 20 mL, and c) 22 mL units, Not for Dispensing, For Hospital Administration Only, Rx Formulations, 5949 East University Drive, Mesa, AZ 85205", "product_quantity": "610 units", "reason_for_recall": "Lack of Assurance of Sterility: The firm expanded the recall to other injectable products due to lack of assurance of sterility from poor aseptic practices observed at the firm.", "recall_initiation_date": "20131212", "center_classification_date": "20140407", "termination_date": "20140501", "report_date": "20140416", "code_info": "a) Lot #: 117460@5 Expiration Date: 12/12/2013, Lot #: 117911@5 Expiration Date: 12/19/2013, Lot #: 118301@9 Expiration Date: 12/25/2013   b) Lot #: 117462@6 Expiration Date: 12/12/2013, Lot #: 117916@6 Expiration Date: 12/19/2013, Lot #: 118305@10 Expiration Date: 12/25/2013   c) Lot #: 118011@23 Expiration Date: 12/18/2013, Lot #: 118092@63 Expiration Date: 12/18/2013, Lot #: 118401@31 Expiration Date: 12/25/2013,    Lot #: 118013@24 Expiration Date: 12/18/2013, Lot #: 118094@64 Expiration Date: 12/18/2013, Lot #: 118403@32 Expiration Date: 12/25/2013"}, {"status": "Terminated", "city": "Toms River", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67810", "recalling_firm": "Pure Edge Nutrition", "address_1": "1182 Fischer Blvd Ste 3", "address_2": "N/A", "postal_code": "08753-3093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1369-2014", "product_description": "Bella Vi INSANE AMP'D Dietary Supplement capsules, 60 count bottles, www.BellaViProducts.com, distributed by Pure Edge Nutrition, LLC, Toms River, NJ", "product_quantity": "unknown", "reason_for_recall": "Marketed without an Approved NDA/ANDA; product was found to contain undeclared sibutramine & phenolphthalein", "recall_initiation_date": "20131010", "center_classification_date": "20140612", "termination_date": "20161007", "report_date": "20140618", "code_info": "lot # VINA2013 EXP: 2015/06/12"}, {"status": "Terminated", "city": "Aiken", "state": "SC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67800", "recalling_firm": "GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline", "address_1": "65 Windham Blvd", "address_2": "N/A", "postal_code": "29805-9384", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1239-2014", "product_description": "Nicotine polacrilex lozenge, 4 mg, Cherry Flavor, 72 count cartons, 81 count cartons, and 108 count cartons. OTC. Labeled a. Nicorette, Distributed By: GlaxoSmithKline Consumer Healthcare, L.P., Moon Township, PA 15108.  Made in Switzerland. 72 Count NDC: 0135-0513-01, 81 Count NDC: 0135-0513-02, 108 Count NDC: 0135-0513-03 b. Nicotine Lozenge Kroger, Distributed by: The Kroger Company, Cincinnati, Ohio 45202, 72 Count NDC:30142-664-01, and c. Nicotine Walgreens, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015. 72 Count NDC: 0363-9200-01.", "product_quantity": "304,332 72 Ct Vials, 85,080 81 Ct Vials  22,992 108 Ct Vials", "reason_for_recall": "Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.", "recall_initiation_date": "20140220", "center_classification_date": "20140418", "termination_date": "20170120", "report_date": "20140430", "code_info": "Labeled A) 72 Ct Vial, Lot # 13481 (exp 5/14), 13674 (exp 5/14), 14056 (exp 2/15), 14092 (exp 3/15), 14258 (exp 7/15), 14450 (exp 10/15); 81 Ct Vial, Lot # 13855 (exp 1/15), 13927 (exp 10/14) & 14093 (exp 3/15); 108 Ct Vial, Lot # 13643 (exp 8/14) & 13992 (exp 12/14). Labeled B) 72 Ct Vial, Lot # 14041 (exp 2/15), 14117 (exp 2/15) & 14268 (exp 4/15); Labeled C) 72 Ct Vial Lot #13671 (exp 8/14) & 13890 (exp 11/14).", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67750", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1226-2014", "product_description": "Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc., Lake Forest, IL.", "product_quantity": "237,850 ampoules", "reason_for_recall": "Labeling; Missing label; ampoules are missing the immediate container label", "recall_initiation_date": "20140325", "center_classification_date": "20140408", "termination_date": "20151218", "report_date": "20140416", "code_info": "Lot: 221303A, 1OCT2014"}, {"status": "Terminated", "city": "Nashville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68557", "recalling_firm": "John W Hollis Inc", "address_1": "110 20th Ave N", "address_2": "N/A", "postal_code": "37203-2315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1393-2014", "product_description": "MIC PLUS B12, Adenosine, L-Carnitine, Contains:  Methionine 15mg, Choline 100mg, Inositol 50mg,  B 12, 0.200mg, Adenosine 20mg, L-Carnitine 30mg/ML, 30ML MULTI DOSE VIAL, BENZYL ALCOHOL AS A PRESERVATIVE, JOHN HOLLIS Pharmacist, Inc, 110 20th Avenue N, Nashville, TN 37203, 615-327-3234", "product_quantity": "210 mL", "reason_for_recall": "Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.", "recall_initiation_date": "20140512", "center_classification_date": "20140618", "termination_date": "20140702", "report_date": "20140625", "code_info": "Lot 1507, Use by 5/18/14; Lot 1863, Use by 7/20/14", "more_code_info": ""}, {"country": "United States", "city": "Irvine", "address_1": "2525 McGaw Ave", "reason_for_recall": "Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.", "address_2": "", "product_quantity": "32,376 units", "code_info": "Lot# H3B702, Exp 02/15", "center_classification_date": "20140425", "distribution_pattern": "Nationwide, Puerto Rico and Spain", "state": "CA", "product_description": "Ceftriaxone for Injection and Dextrose Injection, 1 g in Duplex,  50 mL Container, Catalog Number 3153-11, For IV Use Only, Single Dose, Sterile, Rx Only, B Braun Medical Inc., Irvine CA 92614-5895", "report_date": "20140507", "classification": "Class I", "openfda": {}, "recalling_firm": "B. Braun Medical Inc", "recall_number": "D-1266-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "66913", "termination_date": "20141204", "more_code_info": "", "recall_initiation_date": "20131121", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Nashville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68557", "recalling_firm": "John W Hollis Inc", "address_1": "110 20th Ave N", "address_2": "N/A", "postal_code": "37203-2315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1390-2014", "product_description": "CYANOCOBALAMIN FOR INTRAMUSCULAR OR SUBCUTANEOUS USE ONLY, Each mL contains:  Cyanocobalamin 1000 mcg, , Also Contains: Benzyl Alcohol, Sodium Chloride, Water, Hydrochloric Acid, and/or Sodium Hydroxide, 30 mL, JOHN HOLLIS Pharmacist Inc, 110 20th Avenue N, Nashville, TN 37203, 615-327-3234", "product_quantity": "2650 mL", "reason_for_recall": "Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.", "recall_initiation_date": "20140512", "center_classification_date": "20140618", "termination_date": "20140702", "report_date": "20140625", "code_info": "Lot # 940, Best used by 08/01/14; Lot # 1090, Best used by 08/29/14; Lot # 1533, Best used by 05/24/14; Lot # 1838, Best used by 07/15/14; Lot# 2755, Best used by 10/06/14", "more_code_info": ""}, {"country": "United States", "city": "Vernon Hills", "address_1": "75 N Fairway Dr", "reason_for_recall": "Subpotent Drug: CareFusion is recalling the CareFusion Scrub Care Surgical Scrub Brush-Sponge/Nail Cleaner. The available iodine in the product is less than as stated on the product label.", "address_2": "", "product_quantity": "2,443,500 scrub brushes", "code_info": "4451B; 4451GL", "center_classification_date": "20140605", "distribution_pattern": "Nationwide and Puerto Rico; Bahrain, Germany, Mexico, Philippines", "state": "IL", "product_description": "CareFusion Scrub Care Surgical Scrub Brush-Sponge/Nail Cleaner With 9% Povidone-iodine (USP) Surgical Hand Scrub; CareFusion, Vernon Hills, IL 60061 USA,  NDC 57613-003-18", "report_date": "20140611", "classification": "Class II", "openfda": {}, "recalling_firm": "Carefusion 2200 Inc", "recall_number": "D-1359-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68176", "termination_date": "20150611", "more_code_info": "", "recall_initiation_date": "20131220", "postal_code": "60061-1845", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68402", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd., Suite 3", "address_2": "", "postal_code": "07054", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1355-2014", "product_description": "Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100-count bottle, Rx only. Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Water view Blvd., Parsippany, NJ 07054, USA. NDC: 64679-736-02.", "product_quantity": "8712 Bottles", "reason_for_recall": "Failed Dissolution Specifications: Failure of dissolution test observed at three month time point.", "recall_initiation_date": "20140410", "center_classification_date": "20140529", "termination_date": "20150813", "report_date": "20140604", "code_info": "Lot #: LN11423, Expiry: 8/15/15", "more_code_info": ""}]